A group of 800 hospitals created a nonprofit generic drugmaker called Civica Rx.
The hope is to make generic drugs that are in short supply or have artificially high prices, based on what the hospitals need.
On Wednesday, the organization picked a supplier and two antibiotics to start with in its plan to upend the generic pharma business.
Visit Business Insider’s homepage for more stories.
Hospitals have a creative plan to tackle the high price and frequent shortages of generic drugs.
The nonprofit company, dubbed Civica Rx, was first announced in early 2018, and has gained a lot of attention for its promise of a cheaper and more reliable supply of crucial medicines. In total, 800 hospitals from more than 20 health systems have joined the effort.
Now, Civica has picked its first supplier: Xellia Pharmaceuticals. Xellia, based in Copenhagen, will make antibiotics for the hospitals in Civica’s network, including vancomycin and daptomycin, according to a statement. Overall, Civica has committed to making 14 different drugs this year.
The hospitals that are part of Civica agreed to purchase the drugs for five years from Xellia, and will receive the drugs by the third quarter of this year. The antibiotics business can …read more
Source:: Businessinsider – Life